Sponsor

Queen Mary University of London

Clinical research sponsor

Published trials97
Recruiting shown13
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination StudyNCT06987045 · lead sponsor · 2026-04-04
RECRUITING
Population Based Germline Testing for Early Detection and Prevention of CancerNCT07498829 · lead sponsor · 2025-12-18
RECRUITING
Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast CancerNCT06954480 · lead sponsor · 2025-10-27
RECRUITING
Children's Health, Respiratory Inflammation and Short-term Air PollutionNCT07431021 · lead sponsor · 2025-10-20
RECRUITING
The Barts Charity Children's Environmental Health ClinicNCT06447974 · lead sponsor · 2025-07-24
RECRUITING
Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple SclerosisNCT07111637 · lead sponsor · 2025-06-14
RECRUITING
Εffectiveness of a Digital Social Intervention in Primary CareNCT06849245 · lead sponsor · 2025-02-25
RECRUITING
Cardio-Renal RegistryNCT06521801 · lead sponsor · 2024-08-01
RECRUITING
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersNCT06174948 · lead sponsor · 2024-03-25
RECRUITING
Diagnosing Variable Primary Aldosteronism.NCT05765786 · lead sponsor · 2023-02-24
RECRUITING
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)NCT05418010 · lead sponsor · 2022-12-01
RECRUITING
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple SclerosisNCT03783416 · lead sponsor · 2020-06-15
RECRUITING
Periodontal Assessment of a Bariatric Care PopulationNCT04851470 · lead sponsor · 2014-01-31
RECRUITING
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) StudyNCT07706829 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary AldosteronismNCT07800858 · lead sponsor · 2026-09-15
NOT_YET_RECRUITING
Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma ExacerbationsNCT06885229 · lead sponsor · 2025-03-27
WITHDRAWN
Developing a Learning Health System for Primary Care in ThailandNCT06873243 · lead sponsor · 2024-11-01
ACTIVE_NOT_RECRUITING
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAMNCT05994742 · lead sponsor · 2024-07-15
COMPLETED
Effect of Lower Doses of Colonic Nutrient Supplementation on Appetite Hormones and Food Intake in Obese AdultsNCT07491835 · lead sponsor · 2023-10-18
COMPLETED
Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in ObesityNCT07448519 · lead sponsor · 2023-06-13
COMPLETED
Effect of a Proposed Cav1.3 Inhibitor in Primary AldosteronismNCT05686993 · lead sponsor · 2023-04-24
COMPLETED
Investigating CBF and ICP Using DCSNCT06039098 · lead sponsor · 2023-01-05
COMPLETED
Feasibility of an Asthma Online Social InterventionNCT05829265 · lead sponsor · 2022-12-09
COMPLETED
Assessing the Impact of Non-tailpipe Emissions From Traffic on the Asthmatic AirwayNCT05848791 · lead sponsor · 2022-12-01
COMPLETED
SCRATCH-HTN Study: Evaluating Autonomic Neuromodulation Using Trans-cutaneous Vagal Stimulation in Hypertensive PatientsNCT05179343 · lead sponsor · 2022-08-01
COMPLETED
Implementing Long-Acting Novel AntiretroviralsNCT05294159 · lead sponsor · 2022-07-18
COMPLETED
ADAs to AlemtuzumabNCT06310343 · lead sponsor · 2022-07-12
COMPLETED
Aspirin and Neutrophils in PreeclampsiaNCT04974892 · lead sponsor · 2022-04-27
COMPLETED
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerNCT05533515 · lead sponsor · 2022-02-08
COMPLETED
Bacterial Lysate In Preventing AsthmaNCT05064631 · lead sponsor · 2022-01-12
COMPLETED
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple SclerosisNCT04695080 · lead sponsor · 2021-06-25
ACTIVE_NOT_RECRUITING
Are Diabetics Type 2 More Prone to Dental Caries?NCT04883086 · lead sponsor · 2020-12-15
COMPLETED
Identification of Autoantigens in EGPA and Severe Eosinophilic AsthmaNCT04671446 · lead sponsor · 2020-12-10
COMPLETED
Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast CancerNCT03841747 · lead sponsor · 2020-12-01
WITHDRAWN
Famciclovir in Multiple SclerosisNCT05283551 · lead sponsor · 2020-11-25
UNKNOWN
Personalised Electronic Record Supported Optimisation When Alone for Patients With HypertensionNCT04559074 · lead sponsor · 2020-10-23
COMPLETED
Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With HypertensionNCT06713785 · lead sponsor · 2020-09-26
WITHDRAWN
Under and Over Rehabilitation StudyNCT04490044 · lead sponsor · 2020-09-01
COMPLETED
Cardiac and Immune Cell Function in PreeclampsiaNCT04508582 · lead sponsor · 2020-01-07
COMPLETED
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNceNCT05216172 · lead sponsor · 2019-12-13
COMPLETED
Oral Cladribine B-cell StudyNCT06415864 · lead sponsor · 2019-07-01
COMPLETED
Achieving Control of Asthma in Children In AfricaNCT03990402 · lead sponsor · 2019-05-16
COMPLETED
The Effect of Food Supplements on Food Intake and Gut Hormone LevelsNCT04292236 · lead sponsor · 2019-02-22
COMPLETED
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBCNCT05498896 · lead sponsor · 2018-12-19
ACTIVE_NOT_RECRUITING
Self-management Intervention to Improve Adolescents' Asthma ControlNCT03536416 · lead sponsor · 2018-12-18
COMPLETED
UK Registry for Baroreflex Activation TherapyNCT03730519 · lead sponsor · 2018-11-01
TERMINATED
An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6NCT06978478 · lead sponsor · 2018-06-19
WITHDRAWN
Effect of Dietary Nitrate Ingestion in Heart FailureNCT03511248 · lead sponsor · 2018-06-01
TERMINATED
Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and CarboplatinNCT03498222 · lead sponsor · 2018-06-01
WITHDRAWN
Pre-operative Immunotherapy Combination Strategies in Breast CancerNCT03395899 · lead sponsor · 2017-12-21
COMPLETED
Neurofilaments for NEDA Assessing in MSNCT03250169 · lead sponsor · 2017-08-01
TERMINATED
Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ DamageNCT03088514 · lead sponsor · 2017-03-23
COMPLETED
A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer ProgressionNCT03103152 · lead sponsor · 2016-12-01
COMPLETED
Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT)NCT02880930 · lead sponsor · 2016-12-01
COMPLETED
IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer TypesNCT04285996 · lead sponsor · 2016-03-17
COMPLETED
Robotic Surgery After Focal Ablation TherapyNCT03011606 · lead sponsor · 2016-02-01
COMPLETED
Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast CancerNCT02676986 · lead sponsor · 2015-08-10
COMPLETED
A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced CancersNCT02583542 · lead sponsor · 2015-06-01
UNKNOWN
Th17 Responses Evaluated in RA Patients on Inhibitors of TNFαNCT02620189 · lead sponsor · 2015-03-01
COMPLETED
Protective Role of Oxcarbazepine in Multiple SclerosisNCT02104661 · lead sponsor · 2014-10-01
COMPLETED

Sponsor roles

lead sponsor75
collaborator22

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.